Journey Medical annual return on equity
2021
2022
2023
2024
2025
Journey Medical Return on Equity (ROE) Growth & History (DERM)
Journey Medical's return on equity was −44.03% for fiscal 2025.
View full Journey Medical company overviewJourney Medical annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −44.03% | +28.57 pp |
| 2024 | 2024-12-31 | −72.60% | −51.96 pp |
| 2023 | 2023-12-31 | −20.64% | +79.75 pp |
| 2022 | 2022-12-31 | −100.39% | +67.73 pp |
| 2021 | 2021-12-31 | −168.12% | — |
Journey Medical quarterly return on equity
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −0.99% | +17.62 pp |
| Q1 2026 | 2026-03-31 | −7.12% | +12.46 pp |
| Q4 2025 | 2025-12-31 | −4.32% | −14.13 pp |
| Q3 2025 | 2025-09-30 | −10.26% | +11.26 pp |
| Q2 2025 | 2025-06-30 | −18.61% | +9.11 pp |
| Q1 2025 | 2025-03-31 | −19.58% | +43.14 pp |
| Q4 2024 | 2024-12-31 | 9.81% | +21.18 pp |
| Q3 2024 | 2024-09-30 | −21.51% | −119.25 pp |
| Q2 2024 | 2024-06-30 | −27.72% | — |
| Q1 2024 | 2024-03-31 | −62.71% | — |
| Q4 2023 | 2023-12-31 | −11.36% | +37.95 pp |
| Q3 2023 | 2023-09-30 | 97.74% | +130.80 pp |
| Q4 2022 | 2022-12-31 | −49.31% | +94.10 pp |
| Q3 2022 | 2022-09-30 | −33.06% | — |
| Q2 2022 | 2022-06-30 | −19.75% | — |
| Q1 2022 | 2022-03-31 | −3.30% | — |
| Q4 2021 | 2021-12-31 | −143.41% | — |
Journey Medical return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Journey Medical's return on equity increased from −168.12% to −44.03%, a change of +124.09 percentage points. The latest reported quarter, Q2 2026, shows −0.99%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Journey Medical source filings ↗